A dengue DNA vaccine formulated with Vaxfectin(®) is well tolerated, and elicits strong neutralizing antibody responses to all four dengue serotypes in New Zealand white rabbits

A tetravalent DNA vaccine formulated with Vaxfectin adjuvant was shown to elicit high levels of neutralizing antibody against all four dengue virus serotypes (Porter et al.,(16)), warranting further testing in humans. In preparation for a phase 1 clinical testing, the vaccine and the adjuvant were m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Raviprakash, Kanakatte, Luke, Thomas, Doukas, John, Danko, Janine, Porter, Kevin, Burgess, Timothy, Kochel, Tadeusz
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2012
Assuntos:
Short Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3656063/
https://ncbi.nlm.nih.gov/pubmed/23032166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.21806
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados